Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
PomDoctor Ltd. Unsponsored ADR ( (POM) ) has shared an announcement.
Pomdoctor Limited announced its unaudited financial results for the first half of fiscal 2025, ending June 30, 2025. Despite a challenging economic environment, the company reported a 16.2% increase in net revenue, driven by an 83.2% growth in online pharmacy businesses. The company maintained a stable gross profit margin of 16.2% while managing higher sales and marketing expenses. The successful IPO in October provided additional capital, supporting future growth and strategic initiatives.
More about PomDoctor Ltd. Unsponsored ADR
Pomdoctor Limited is a leading online medical services platform in China, focusing on chronic diseases. The company offers internet-hospital services and online pharmacy sales, collaborating with pharmaceutical manufacturers to enhance its market presence.
Average Trading Volume: 2,328,757
Current Market Cap: $555.4M
Find detailed analytics on POM stock on TipRanks’ Stock Analysis page.
